Medpace Holdings Inc

1MEDP

Company Profile

  • Business description

    Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.

  • Contact

    5375 Medpace Way
    CincinnatiOH45227
    USA

    T: +1 513 579-9911

    E: [email protected]

    https://www.medpace.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Diagnostics & Research

    Fiscal Year End

    31 December 2026

    Employees

    6,300

Stocks News & Analysis

stocks

We lift our fair value estimate for this ASX energy play

Strong oil and LNG prices are a major win, though we don’t think they will stay high in the long term.
stocks

Chart of the Week: Headwinds for Aussie banks point to an imminent slowdown

Investor demand is expected to fade and slow credit growth as borrowers face higher costs and reduced tax breaks.
stocks

Hostile takeover on the cards for this ASX income opportunity

IFM lobs reasonable takeover offer.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,915.7016.000.18%
CAC 408,072.1331.96-0.39%
DAX 4023,954.5663.70-0.27%
Dow JONES (US)48,861.81280.12-0.57%
FTSE 10010,213.11119.68-1.16%
HKSE26,111.84432.061.68%
NASDAQ24,673.249.440.04%
Nikkei 22559,917.46619.90-1.02%
NZX 50 Index12,811.5341.230.32%
S&P 5007,135.952.85-0.04%
S&P/ASX 2008,687.009.400.11%
SSE Composite Index4,107.5128.880.71%

Market Movers